We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
-1.9%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$169M
AUM Growth
-$15.1M
(-8.2%)
Cap. Flow
-$22.7M
Cap. Flow
% of AUM
-13.45%
Top 10 Holdings %
Top 10 Hldgs %
33.65%
Holding
197
New
30
Increased
43
Reduced
28
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aspen Aerogels
ASPN
|
+$3.04M |
| 2 |
VCNX
Vaccinex, Inc. Common Stock
VCNX
|
+$2.57M |
| 3 |
ALIM
Alimera Sciences
ALIM
|
+$1.96M |
| 4 |
Ouster
OUST
|
+$1.74M |
| 5 |
Silicom
SILC
|
+$1.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$5.37M |
| 2 |
ANI Pharmaceuticals
ANIP
|
+$4.71M |
| 3 |
Aviat Networks
AVNW
|
+$1.76M |
| 4 |
Annovis Bio
ANVS
|
+$1.14M |
| 5 |
CMBM
Cambium Networks
CMBM
|
+$1.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.95% |
| 2 | Technology | 14.24% |
| 3 | Financials | 7.09% |
| 4 | Industrials | 3.96% |
| 5 | Consumer Staples | 1.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDN
76
Brandywine Realty Trust
BDN
$544M
| $193K | 0.11% |
42,500
-13,000
| -23% | -$61.9K |
|
77
Ribbon Communications
RBBN
$386M
| $181K | 0.11% |
67,588
+8,917
| +15% | +$26K |
|
|
IMGN
78
CALL
DELISTED
Immunogen Inc
IMGN
| $172K | 0.1% |
156,200
+45,600
| +41% | +$758K |
|
79
CALL
Sarepta Therapeutics
SRPT
$1.68B
| $171K | 0.1% |
+11,200
| New | +$1.27M |
|
80
Coda Octopus Group
CODA
$119M
| $167K | 0.1% |
+26,947
| New | +$208K |
|
81
Syndax Pharmaceuticals
SNDX
$1.72B
| $158K | 0.09% |
10,900
| – | – |
|
82
Zeta Global
ZETA
$5.85B
| $154K | 0.09% |
18,421
-3,579
| -16% | -$29.5K |
|
83
Ceragon Networks
CRNT
$205M
| $152K | 0.09% |
74,097
+8,700
| +13% | +$17.6K |
|
84
Lantronix
LTRX
$265M
| $138K | 0.08% |
31,123
-1,255
| -4% | -$5.51K |
|
|
85
Annovis Bio
ANVS
$74M
| $117K | 0.07% |
12,321
-92,330
| -88% | -$1.14M |
|
|
OPRA
86
Opera Ltd
OPRA
$1.78B
| $116K | 0.07% |
10,276
-3,327
| -24% | -$55.7K |
|
87
Applied Digital
APLD
$8.61B
| $106K | 0.06% |
16,914
+978
| +6% | +$6.83K |
|
88
Asure Software
ASUR
$252M
| $103K | 0.06% |
10,897
-3,403
| -24% | -$41.2K |
|
|
OSA
89
DELISTED
ProSomnus, Inc. Common Stock
OSA
| $100K | 0.06% |
91,244
-5,105
| -5% | -$7.71K |
|
90
CS Disco
LAW
$265M
| $88.8K | 0.05% |
+13,376
| New | +$117K |
|
91
DocGo
DCGO
$63.8M
| $85.4K | 0.05% |
16,028
+4,265
| +36% | +$34.6K |
|
|
AUGX
92
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $82.8K | 0.05% |
+16,086
| New | +$75.5K |
|
|
GRTS
93
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $75.3K | 0.04% |
43,772
| – | – |
|
|
AIOT
94
PowerFleet Inc
AIOT
$562M
| $64.4K | 0.04% |
31,111
+4,679
| +18% | +$11.2K |
|
95
LifeMD
LFMD
$183M
| $64.2K | 0.04% |
+10,269
| New | +$44.5K |
|
96
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.7B
| $63.4K | 0.04% |
+14,600
| New | +$1.94M |
|
|
97
PUT
Syndax Pharmaceuticals
SNDX
$1.72B
| $61K | 0.04% |
10,900
| – | – |
|
|
CASA
98
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $59.4K | 0.04% |
70,090
-19,404
| -22% | -$18.9K |
|
99
Mama's Creations
MAMA
$885M
| $51.3K | 0.03% |
11,750
| – | – |
|
|
NOTE
100
DELISTED
FiscalNote
NOTE
| $46.5K | 0.03% |
1,864
-1,859
| -50% | -$63.6K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Worth Venture Partners held 197 positions worth $169M, down 8.2% from $184M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Worth Venture Partners withdrew a net $22.7M in Q3 2023, closing 35 positions and reducing 28 holdings. Its most notable exit was ANI Pharmaceuticals, an estimated $4.71M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, Worth Venture Partners opened a new position in Aspen Aerogels worth $3.68M.
- Worth Venture Partners's largest Q3 2023 buy was Aspen Aerogels: 428,367 shares worth $3.68M.
- Worth Venture Partners added most to Vaccinex, Inc. Common Stock in Q3 2023, an estimated $2.57M increase.
- Worth Venture Partners's biggest Q3 2023 reduction was Microchip Technology, cutting an estimated $5.37M.
- Worth Venture Partners fully exited ANI Pharmaceuticals in Q3 2023, selling an estimated $4.71M.
- Worth Venture Partners's ten largest holdings make up 34% of its $169M portfolio in Q3 2023.
- Worth Venture Partners opened 30 new positions and closed 35 in Q3 2023.
- Worth Venture Partners's portfolio value fell 8.2% quarter-over-quarter to $169M.
Based on Worth Venture Partners's 13F filing for Q3 2023, filed 15 Nov 2023.